Conformational bias in SARS-CoV-2 Spike CD4+ T-cell epitope dominance - Scorecard - MDSpire

Conformational Influence on Dominance of CD4+ T-cell Epitopes in SARS-CoV-2 Spike Protein

  • By

  • Samuel J. Landry

  • N. Kalaya Steede

  • Yali Tiomkin

  • Haley Smith

  • Ramgopal R. Mettu

  • Loren Gragert

  • Judith H. Aberle

  • Kevin J. Zwezdaryk

  • Crystal Zheng

  • Jay K. Kolls

  • Bronwyn M. Gunn

  • Amelie E. Murrell

  • Ivy V. Trinh

  • John S. Schieffelin

  • James E. Robinson

  • Elizabeth B. Norton

  • July 20, 2026

Share

Clinical Scorecard: Conformational Influence on Dominance of CD4+ T-cell Epitopes in SARS-CoV-2 Spike Protein

At a Glance

CategoryDetail
ConditionSARS-CoV-2 Spike Protein Immunology
Key MechanismsInfluence of antigen conformation on CD4+ T-cell epitope dominance and proteolytic processing.
Target PopulationIndividuals exposed to SARS-CoV-2 via infection or vaccination.
Care SettingImmunological research and vaccine development.

Key Highlights

  • CD4+ T-cell responses are influenced by the conformation of the SARS-CoV-2 spike protein.
  • Protease-sensitive sites correspond to conformationally unstable regions of the spike.
  • Different exposure circumstances (infection vs. vaccination) affect T-cell epitope dominance.
  • CD4+ T cells play a critical role in adaptive immunity against SARS-CoV-2.
  • Immune imprinting may shape the CD4+ T-cell response patterns.

Guideline-Based Recommendations

Diagnosis

  • Assess CD4+ T-cell responses to SARS-CoV-2 spike protein for understanding immune status.

Management

  • Consider the impact of vaccination and infection history on T-cell epitope dominance.

Monitoring & Follow-up

  • Monitor CD4+ T-cell responses to evaluate vaccine efficacy and immune protection.

Risks

  • Inadequate immune responses may occur due to variations in antigen exposure.

Patient & Prescribing Data

Non-hospitalized individuals with prior exposure to SARS-CoV-2.

Vaccination with spike protein may enhance long-term CD4+ T-cell responses.

Clinical Best Practices

  • Utilize Elispot assays to quantify CD4+ T-cell responses.
  • Incorporate understanding of antigen conformation in vaccine design.
  • Evaluate the role of immune history in shaping T-cell responses.

Related Resources & Content

Original Source(s)

Related Content